Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing

This document is a response-to-comments notice for MolDX LCD L38988; it records the public comment period (2021-05-20 to 2021-07-03), the notice and effective dates (notice 2022-03-03, effective 2022-04-17), and a title revision to reference molecular syndromic panels. The document does not present specific clinical coverage, limitation, or frequency criteria — consult LCD L38988 for the detailed coverage policy and clinical requirements.

"Public comment period for MolDX LCD L38988 ran from 2021-05-20 to 2021-07-03."

Sign up to see full coverage criteria, indications, and limitations.